Peru vs United States of America: Proportion of isolates with decreased susceptibility or resistance
Peru
0
in 2020
United States of America
0
in 2020
Peru rank
13th
United States of America rank
13th
Proportion of isolates with decreased susceptibility or resistance over time
- Peru
- United States of America
How they compare
Peru currently reports 0 against 0 in United States of America, a difference of 0.
The two have swapped places 2 times across 7 shared years of data; in 2009 it was United States of America ahead.
Peru ranks 13th and United States of America ranks 13th of 52 countries.
Across the 3 decades both report, Peru averaged higher in 1 and United States of America in 1.
Head to head by decade
| Decade | Peru | United States of America | Difference | Ahead |
|---|---|---|---|---|
| 2000s | 0 | 0.2842 | 0.2842 | United States of America |
| 2010s | 0.4762 | 0.2096 | 0.2666 | Peru |
| 2020s | 0 | 0 | 0 | — |
Averages of every year both report within each decade.
Frequently asked questions
- Which has higher proportion of isolates with decreased susceptibility or resistance, Peru or United States of America?
- Peru, at 0 against 0 in United States of America as of 2020.
- What is the difference in proportion of isolates with decreased susceptibility or resistance between Peru and United States of America?
- 0, with Peru ahead.
- How many years of comparable data are there for Peru and United States of America?
- 7 years are reported by both, from 2009 to 2020.
- How do Peru and United States of America rank globally for proportion of isolates with decreased susceptibility or resistance?
- Peru ranks 13th and United States of America ranks 13th of 52 countries.
- Where does this data come from?
- World Health Organization, Global Health Observatory, published as Proportion of isolates with decreased susceptibility or resistance (DS/R) to ceftriaxone reported to WHO-GASP. Statizoid refreshes it automatically from the source and publishes the full history for both places.